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Abstract 
Background  
Symptoms of transient ischaemic attack (TIA) are believed to fully resolve within 24 hours of 
onset. Emerging evidence suggests that there may be prolonged functional and psychological 
impact, although studies have not been able to robustly identify whether these are the effect 
of TIA or changes usually associated with ageing. We describe trajectories of disability and 
risk of anxiety and depression among patients seen at TIA clinics over twelve months, 
compared to healthy controls. 
Methods 
Thirty TIA clinics across England participated. 1320 participants were included: 373 
diagnosed with TIA, 186 with minor stroke, 310 with ‘possible TIA’, 213 with another 
condition mimicking a TIA and 238 controls recruited from primary care providers. 
Participants completed questionnaires after diagnosis then after three, six and twelve months. 
Outcomes were the Nottingham Extended Activities of Daily Living scale, and the Hospital 
Anxiety and Depression Scale. Mixed effects regression was used to estimate group 
differences and trajectories. 
Results 
At baseline, confirmed TIA patients scored 1.31 (s.e=0.28; p<0.001) HADS-Anxiety points, 
0.51 HADS-Depression points (s.e=0.26; p=0.056) and 2.6 NEADL points (s.e=1.1; p=0.020) 
worse than controls. At 12 months, the deficits were 0.78 (s.e=0.30; p=0.008), 0.97 (s.e=0.23; 
p<0.001) and 0.96 (s.e=0.92; p=0.294) respectively. Differences among patients diagnosed 
with minor stroke were like or worse than TIA patients.  
Conclusions 
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TIA clinic patients may have functional and emotional impairments compared to the general 
population irrespective of final diagnosis. The presence of emotional symptoms or risk of 
developing anxiety or depression did not always fully recover and may increase. 
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Introduction 
Transient Ischemic Attack (TIA) are brief episodes of neurological dysfunction resulting 
from focal cerebral ischaemia not associated with permanent cerebral infarction1.  An 
estimate for the incidence of first-ever TIA in the UK is 50 people/100,000 population/year2. 
Approximately 11-14% will have a stroke within the first week following TIA, referral to a 
TIA clinic can reduce the relative risk by 80%3. There were approximately 150,000 new 
referrals to TIA clinics in England in 20054.   
Management and most existing research on TIA focuses on prescription of prophylactic 
medications and prevention of cardiovascular episodes or death5.It was assumed that patients 
did not experience long term sequelae related to TIA. However uncontrolled studies or those 
relying on routinely collected primary care data suggest that there are residual psychological 
and functional impairments6, 7 that are important to patients and families8. These have 
however not been able to determine whether any residual changes were because of a healthy 
ageing process. We are unaware of any controlled study using primary data collection that 
has investigated the long-term effects of functional, emotional and cognitive outcomes in the 
first year following referral to TIA clinics in England with suspected TIA. 
Aims 
We undertook a controlled prospective observational study (FACE-TIA) of patients attending 
TIA clinics to understand how mood, cognitive and functional outcomes differ from the 
general population in the year following clinic attendance. We report their baseline deficits 
and subsequent trajectories of functional and emotional outcomes over 12 months, stratified 
by final clinic diagnosis and compared to a control sample of patients.  Cognitive outcomes 
were measured with the Birmingham Cognitive Screen9. Measurement was discontinued and 
is not reported here because there was insufficient data to be able to make any inferences 
about the population sampled.  
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Methods 
Design 
A controlled prospective observational study including participants identified from TIA 
clinics and matched controls.  
Setting 
Thirty TIA clinics across four regions of England were identified following a call for 
expressions of interest via the National Stroke Research Network. Controls were recruited by 
the Primary Care Research Network (PCRN) from General Practices within the same 
geographical areas as the TIA clinics. 
Population  
The target population for FACE-TIA was the UK population without previous stroke or TIA, 
attending a TIA clinic.  Patients attending from September 2010 to December 2012 were 
eligible for inclusion in the study if their appointment was for a new incident, they attended 
and received a final diagnosis within 14 days of their event, had no previous history of stroke 
or TIA and were deemed by a consultant stroke physician or neurologist to be able to self-
complete postal questionnaires (no known cognitive impairment that would prohibit self-
completion of questionnaires).  
Following informed consent participants were assigned a study diagnosis by the consultant, 
(attending) stroke physician or neurologist at the TIA clinic..  
(i) Confirmed TIA: a transient episode of neurological dysfunction caused by focal 
brain, spinal cord, or retinal ischemia, without acute infarction 1. 
(ii) Minor stroke: prolonged deficits suggestive of focal or global cerebral, spinal, or 
retinal dysfunction caused by central nervous system infarction1, not requiring 
hospital admission. 
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(iii) TIA mimic: another condition mimicking the symptoms of TIA (e.g. migraine, 
seizure and sepsis10. 
(iv) Possible TIA: Clinical symptoms suggestive of TIA but insufficient evidence to 
make a clinical diagnosis of either TIA, stroke or TIA mimic.  
Controls were recruited from primary care following identification from practice patient 
registers with the help of the Primary Care Research Network (PCRN). Practices within the 
same geographical areas as the TIA clinics were chosen based on their postcode meta-data, 
specifically urban-rural indicators and indices of multiple deprivation. Participating practices 
provided the study team with an anonymous database containing year of birth, gender and a 
unique ID for each of their patients from which potential controls without history of stroke or 
TIA were selected. To provide balance across key covariates, controls were recruited to 
match the demographic characteristics of confirmed TIA cases.  
Participants were included from the time of recruitment to the first of withdrawal, death, loss 
to follow-up or new stroke. 
Data collection and analysis 
Self-completion questionnaires were given to participants or sent by mail on recruitment. 
Follow-up questionnaires were sent by mail at three, six and twelve months after the baseline.   
Data were collated anonymously and all analyses were carried out using Stata version 14.0. 
Mixed effects multilevel regression was used to model continuous outcome measures across 
time within individuals. Sociodemographic (age, sex, educational attainment and area-level 
deprivation) and number of chronic diseases and smoking status were included as covariates.  
Statistical significance corresponds to p<0.05 for each comparison, but a second critical 
threshold of p<0.0042 is also shown calculated using the method of Benjamini and 
Hochberg11 to correct for the large number of hypotheses being tested.  The interaction of 
time (as a categorical variable) by group was included in each model to estimate the 
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trajectories of each outcome in each group. Weighted prevalence of case-level anxiety and 
depression was estimated at each time point. 
As subgroup analyses, we explored the effects on each primary outcome at baseline stratified 
by age group and by sex, and tested age and sex specific effects by adding the interactions 
with age or sex as appropriate to each mixed model.   
 
Measures 
Functional ability was measured using the Nottingham Extended Activities of Daily Living 
(NEADL) scale11. NEADL includes 22 items that measure independence in everyday 
activities and societal participation in four domains: mobility, ‘kitchen’ related activities, 
other ‘domestic’ activities and leisure activities.  Each activity is scored as 0 (not done), 1 
(done with help), 2 (on my own with difficulty) or 3 (on my own). The maximum score is 66, 
higher scores reflect greater independence. 
Emotional outcomes were measured using the Hospital Anxiety and Depression Scale 
(HADS),  a screening tool for anxiety (HADS-A), and depressive symptoms (HADS-D) that 
is not dependent on physical symptoms13. HADS includes seven depression (HADS-D) and 
seven anxiety items (HADS-A), each scored 0-3. HADS is scored out of 42 or 21 for each 
subscale with higher scores indicating worse symptoms; 0.5 represents a moderate effect size 
corresponding to a minimally important difference14. 
Data also collected at each assessment included self-reported diagnoses of other health 
conditions, physical activity, smoking and alcohol use. 
 
Ethical approval 
The study was approved by NRES Committee West Midlands – Solihull:10/H1206/36. 
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Results 
Characteristics of the sample 
Of 1,698 participants recruited, 1287 (76%) were included at baseline (figure 1). 232 (18%) 
controls, 364 (28%) with confirmed TIA, 183 (14%) with minor stroke, 297 (23%) with a 
‘possible’ TIA and 211 (16%) with TIA mimic.  Baseline questionnaires were sent within a 
median of 4 (IQR 2-8) days from the index event (Table 1). Participants were balanced with 
respect to the Index of Multiple Deprivation (IMD), but controls were more likely to have 
completed a degree (24%) than TIA cases (14%) or other groups. 85% of participants had 
complete covariate and outcome data at baseline, so complete case analyses was used 
throughout. 75% of participants completed 12-month follow-up; 91% of controls returned the 
12-month questionnaire compared to 69% of TIA, 74% of stroke, 64% of possible TIA and 
66% of ‘TIA mimic’ cases.   
 
Functional and emotional outcome 
Figure 2 shows the distributions of HADS and NEADL across groups and table 2 shows the 
baseline means of each outcome with standard deviation, suggesting a considerable degree of 
overlap but significantly worse average scores for clinic attendees than controls irrespective 
of final diagnosis. 
Anxiety 
At baseline, all clinic referral groups had significantly worse anxiety scores than controls 
(table 2; figure 3).  There was a statistically significant improvement in anxiety among the 
TIA, possible TIA and TIA mimic groups between baseline and 12 months, but not for 
controls or patients diagnosed with stroke (table 3).   
Depression 
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HADS-D scores were significantly worse among stroke and possible TIA groups compared to 
controls at baseline, but not for people with TIA or TIA mimic (table 2; figure 3).  
Depression became worse in the TIA group, becoming significantly worse than in controls at 
12 months (table 2; figure 3).  Depression remained worse than controls among possible TIA 
and stroke patients at 12 months (table 2).  Although improvements in anxiety were 
statistically significant after correcting for multiple testing (table 3) none of the changes in 
depression scores within groups were as statistically significant and directions of change were 
mixed across groups. 
NEADL 
NEADL scores were lower among clinical groups than controls at baseline, although this was 
not statistically significant for TIA mimic group. NEADL scores improved in the TIA and 
stroke group over the 12 months of follow-up  (table 3). 
Subgroup analysis 
There was no interaction between sex and diagnosis group for any baseline outcome (not 
shown).  There were significant interactions between age and diagnosis group for emotional 
outcomes (supplemental table VI).  We found that those under 70 with TIA, stroke and 
possible TIA had clinically and statistically significant increased depression and anxiety 
scores compared to control.  
Sensitivity analysis 
The pattern of results was not substantially altered when transformations to remove skew 
were applied to primary outcomes before estimating regression models (supplemental tables 
VII, VIII, and supplemental figure I). 
Discussion 
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We demonstrated that people attending TIA clinics have functional and emotional deficits 
when compared to the general population, particularly among people aged under 70 years. 
TIA or other diagnoses was not confirmed by a standardised protocol, but by the clinicians at 
each clinic and given that there is no diagnostic test for TIA, there may be overlap between 
people labelled as ‘TIA’, ‘possible TIA’ and ‘mimic’. The study is of high clinical relevance 
for those people attending TIA clinics in the UK Neuroimaging studies of people with TIA 
have indicated that despite the potential for restoration of clinical symptoms evidence of 
brain damage is present on MRI1. Such damage may explain the presence of symptoms in the 
longer term but the lack of a control group in previous studies to FACE-TIA has not been 
able to robustly support this.  
Patterns of deficits among those referred to TIA clinic but finally diagnosed with possible 
TIA or another condition mimicking a TIA were typically more like those diagnosed with 
TIA or stroke than to the healthy population.  Degree level education was more prevalent in 
our control group than the diagnostic groups. This is unsurprising considering the reported 
positive relationship between education and health and was controlled for in regression 
analyses15. Anxiety was elevated in clinic attendees who did not have a confirmed TIA or 
stroke compared to controls, but the difference was not significant at 12 months. This most 
likely reflects the uncertainty caused by referral or due to other morbidity, but could also 
indicate a lower threshold for referral in anxious patients.  
Despite improvements over the period of the study people diagnosed with TIA, possible TIA 
or stroke remained more likely to show symptoms of anxiety and less able to carry out 
activities of daily living than the control group at 12 months.  
Symptoms of depression scores were worse than controls for TIA, possible TIA and stroke 
patients at 12 months and did not improve for the TIA mimic group. 
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Despite patient reported concerns8, little follow up data has been published describing anxiety 
after TIA. Our systematic review6 identified only the pilot study of FACE-TIA15 and data 
from an uncontrolled cohort of 49 non-severe stroke survivors at 12 months post event16.  
Since our review was conducted a cross sectional survey of 1247 patients from Glasgow, UK, 
estimated the prevalence of anxiety following TIA using a HADS cut-off of 11 to be 14%, 
identical to our finding but did not report longitudinal data17.  
More data are available on depression after TIA and minor stroke: between 8-42% experience 
depression within the first year post event, but again there are methodological shortcomings 
in many studies and time post-event is not recorded or is not consistent for the largest 
studies6.  In the cross-sectional survey discussed above, the population prevalence of 
probable depression (based on HADS-D score of 11 or more) after TIA was 9%, higher than 
our estimated prevalence of 4.3% (95% CI=2.3-7.8), possibly reflecting differences in 
geographic location between studies17.  
Anxiety and depression were elevated in clinic attendees who did not have a confirmed TIA 
or stroke compared to controls, perhaps associated with the uncertainty caused by referral or 
due to other morbidity.   
A deterioration in functional ability may contribute to the loss of self-confidence and feelings 
of insecurity in carrying out normal functions reported by patients following a TIA18.  
The worsening depression in TIA group could reflect a vascular cause of depression19. An 
analysis of participants from the Whitehall study showed that depressive symptoms were 
linked to incident stroke risk and may reflect deteriorating cerebrovascular health20. The 
‘possible TIA’ group had higher depression and anxiety scores than the TIA group and so 
emotional support may be needed for TIA referrals irrespective of final diagnosis. 
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This is the first prospective controlled study of people attending a TIA clinic compared to 
controls. We did not record potential confounders such as therapy received by participants 
during the follow up period however, the findings suggest that there are sufficient adverse 
psychological and functional consequences of TIA, minor stroke and other conditions 
referred to a TIA clinic to merit further attention – and intervention, both in terms of research 
and clinical rehabilitation.  
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Figures and tables for FACE main paper 
 
 
Figure 1:  Participant flow through the study. 
 
   
Recruited (n=1698)
Baseline Questionnaire Returned (n=1312)
Included in Baseline Analysis (n=1287)
3 month (n=1101)
6 month (n=1025)
12 month (n=927)
Loss to follow-up: 168
Incident stroke in non-stroke group: 18
Incident TIA in control: 0
Loss to follow-up: 61
Incident stroke in non-stroke group: 13 
Incident TIA in control: 2
Loss to follow-up: 88
Incident stroke in non-stroke group: 10
Incident TIA in control group: 0
Previous stroke reported in non-stroke group: 18
Previous TIA reported in control group: 6
Unknown diagnosis: 1
Questionnaire not returned: 358
Delay to clinic more than 14 days: 28 
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Figure 2: 
Box plots showing baseline distribution of HADS-A (panel A), HADS-D (panel B) and 
NEADL (panel C) scores among controls and cases stratified by diagnosis group 
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Figure 3: 
 
Trajectories of group marginal means of anxiety (panel A) depression (panel B) and function 
(panel C) over 12 months from diagnosis in control (hollow circles), TIA (filled circles) and 
minor stroke (no marker) groups.  Error bars represent 95% confidence intervals.  Estimates 
are standardised to sample means of baseline covariates.  Numerical values for primary 
outcomes across all diagnosis groups (supplemental tables III-V), and a figure showing the 
trajectories among the ‘possible TIA’ and ‘TIA mimic’ groups compared to controls 
(supplemental figure III) are supplied in the supplementary appendix. 
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Table 1.   Demographic, clinical characteristics and baseline outcome measures of FACE-
TIA participants stratified by study diagnosis group. 
  Control TIA Stroke Possible 
TIA 
TIA Mimic 
N=232 N=364 N=183 N=297 N=211 
Age (mean, sd) 69.9 (9.7) 69.8 (11.8) 67.7 (13.1) 66.4 (13) 62 (14.7) 
Index of Multiple 
Deprivation (mean, sd) 
20.5 (12.9) 17.7 (12.4) 22.3 (15.8) 18.9 (13.2) 19.6 (13.6) 
Female (N,%) 98 (42.2) 151 (41.5) 84 (46.2) 148 (50) 110 (52.1) 
Degree level education 
(N,%) 
54 (23.3) 52 (14.3) 15 (8.2) 46 (15.5) 38 (18) 
Secondary level education 
only 
80 (34.5) 123 (33.8) 69 (37.7) 120 (40.4) 85 (40.3) 
No formal qualification 55 (23.7) 124 (34.1) 55 (30.1) 68 (22.9) 58 (27.5) 
Other qualification 
(unknown level) 
43 (18.5) 65 (17.9) 44 (24.0) 63 (21.2) 30 (14.2) 
Number of reported chronic 
diseases* (mean, sd) 
1.83 (1.77) 1.85 (1.85) 1.73 (1.82) 1.75 (1.79) 1.84 (1.88) 
Smoker (N,%) 11 (4.8) 55 (15.6) 30 (16.9) 27 (9.5) 30 (14.4) 
Days walking per week 
(mean, sd) 
5.2 (2.1) 4.4 (2.7) 4.2 (2.8) 4.4 (2.6) 5 (2.5) 
Days moderate activity per 
week (mean, sd) 
2.5 (2.5) 1.3 (2.1) 1.4 (2.2) 1.6 (2.2) 1.9 (2.3) 
Days vigorous activity per 
week (mean, sd) 
1.5 (2.0) 0.7 (1.7) 0.7 (1.5) 0.8 (1.6) 1 (1.8) 
HADS-A (mean, sd) 4.2 (3.7) 5.7 (4.5) 5.8 (4.6) 6.4 (4.6) 6.3 (4.4) 
Case level anxiety (N, %) 14 (6.2) 48 (13.9) 27 (15.3) 56 (20) 35 (17) 
HADS-D (mean, sd) 2.8 (2.9) 3.5 (3.3) 4.2 (3.4) 4 (3.5) 3.4 (3.2) 
Case level depression (N, %) 3 (1.3) 15 (4.3) 12 (6.8) 16 (5.7) 7 (3.4) 
Full NEADL (mean, sd) 57.5 (11.3) 54.2 (11.1) 52.7 (12.1) 54.6 (12.5) 56.5 (10.6) 
NEADL Mobility (mean, sd) 15.5 (3.5) 14.7 (3.9) 14.4 (4) 14.9 (4.0) 15.3 (3.6) 
NEADL Kitchen (mean, sd) 14.3 (2.4) 14.2 (2.3) 14.1 (2.4) 14.1 (2.4) 14.3 (2.0) 
NEADL Domestic (mean, sd) 15.4 (4.1) 14.4 (4.4) 14.2 (4.7) 14.6 (4.6) 14.9 (4.2) 
NEADL Leisure (mean, sd) 12.3 (3.4) 10.9 (3.9) 10 (3.9) 11 (4.0) 12 (3.5) 
* Number of previously diagnosed conditions from arthritis, osteoporosis, asthma, COPD, 
Angina, heart disease, any neurological disease, peripheral vascular disease, diabetes (type 1 
or type 2), upper gastrointestinal disease, previously diagnosed depression, diagnosed 
anxiety, visual impairment, hearing impairment, degenerative disc disease, and obesity.  
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Table 2 
 
Difference in HADS-A (anxiety), HADS-D (depression) and NEADL (disability) scores for 
each clinic group compared to controls, at baseline and 12 months.  Estimates are derived 
from linear mixed models, attrition weighted and adjusted for covariates at baseline.  
Estimates are shown with standard errors.  Stars correspond to statistical significance at 
p<0.05, and at p<0.0042, with p<0.0042 the critical p-value that controls the study wide false 
discovery rate at q0.05. 
 
 
 
HADS-A  HADS-D  NEADL  
 
 
Effect (se) p-value Effect (se) p-value Effect (se) p-value 
Baseline Control 0 (Ref.)  0 (Ref.)  0 (Ref.)  
 TIA 1.31** (0.28) <0.001 0.51 (0.27) 0.056 -2.63* (1.13) 0.020 
 Stroke 1.24** (0.41) 0.002 1.20** (0.32) <0.001 -4.74** (1.45) 0.001 
 Possible TIA 1.72** (0.27) <0.001 0.99** (0.27) <0.001 -3.39* (1.21) 0.005 
 TIA Mimic 1.26** (0.35) 0.001 0.40 (0.30) 0.173 -1.94 (1.10) 0.078 
12 Months Control 0 (Ref.)  0 (Ref.)  0 (Ref.)  
 TIA 0.78* (0.30) 0.008 0.97** (0.23) <0.001 -2.63* (1.13) 0.020 
 Stroke 1.06* (0.45) 0.018 1.56** (0.33) <0.001 -4.74** (1.45) 0.001 
 Possible TIA 0.70* (0.33) 0.036 0.52* (0.26) 0.046 -3.39* (1.21) 0.005 
 TIA Mimic 0.45 (0.35) 0.198 0.54 (0.35) 0.125 -1.94 (1.10) 0.078 
 
 
 
* p<0.05 **p<0.0042 
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Table 3: Change in anxiety, depression and disability between baseline and 12 month follow-
up.  Change is estimated using an attrition weighted mixed model and is estimated 
independently for each outcome.  Estimates are shown with standard errors and p-values.  
Stars correspond to statistical significance at p<0.05 and at p<0.0042, with p<0.0042 the 
critical threshold required for a study wide false discovery rate of q=0.05. 
 
 
  HADS-A   HADS-D   NEADL 
 
  Change (s.e.) p Change (s.e.) p Change (s.e.) p 
Control -0.10 (0.12) 0.417 -0.10 (0.10) 0.335 0.25 (0.93) 0.789 
TIA -0.63** (0.21) 0.003 0.36 (0.19) 0.065 1.91* (0.80) 0.017 
Stroke -0.28 (0.16) 0.070 0.26 (0.27) 0.326 3.29** (0.90) <0.001 
Possible TIA -1.11** (0.28) <0.001 -0.57* (0.23) 0.011 1.36 (0.83) 0.101 
TIA mimic -0.91** (0.27) 0.001 0.03 (0.31) 0.921 -0.35 (1.09) 0.749 
 
* p<0.05; ** p<0.0042 
 
 
 
 
